US FDA panel discusses Covid vax for kids under 12

US


Washington, June 11 : A key panel of the US Food and Drug Administration (FDA) held a meeting during which they discussed the potential use of Covid-19 vaccines in children under 12 years of age. The FDA's Vaccines and Related Biological Products Advisory Committee met in the open session on Thursday to discuss data needed to support authorization and/or licensure of Covid-19 vaccines for use in paediatric populations, Xinhua news agency. The meeting came on the same day that Moderna said it has applied for authorisation from the FDA to expand the emergency use of its Covid-19 vaccine in adolescents ages 12 to 17. The vaccine was authorised for adults last December. If authorised, Moderna vaccine will be the second one for use in children aged 12 to 17 years old in the US. The FDA approved the emergency use of Pfizer-BioNTech Covid-19 vaccine in children aged 12 to 15 on May 10. /IANS




Related

US FDA panel discusses Covid vax for kids under 12
Washington, June 11 : A key panel of the US Food and Drug Administration (FDA) held a meeting during which they discussed the potential use of Covid-1

Biophore seeks DCGI approval for Aviptadil for Covid treatment
Hyderabad, June 11 : Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptad

African nations acquire nearly 55mn Covid vaccines
Addis Ababa, June 11 : African countries have acquired nearly 55 million Covid-19 vaccines so far, according to health authorities. The Africa C